What is the Org number of Noursken AB?

Noursken AB is registered with Bolagsverket / SCB under Org 5592648256.

What is the revenue of Noursken AB?

Noursken AB reported revenue of SEK 1,5M in 2025.

Who is the chairman of Noursken AB?

Mazen Saber chairs the board of Noursken AB, in role since 2022.

Where is Noursken AB headquartered?

Noursken AB's registered address is Skvadronsbacken 64.

Noursken AB

ABActive

Org 5592648256Skvadronsbacken 64Business and other management consultancy activities · NACE 7020Est. 20205-9 employees

Full Risika report

Revenue 2025

SEK 1,5M

-14% vs 2024

EBITDA margin

28.8%

-48% vs 2024

Equity ratio

70.6%

Financial strength

Net profit 2025

SEK 261K

-48% vs 2024

EBITDA — year on yearSEK millions

Key figuresAnnual report 2025

Revenue	SEK 1,5M	-14%
EBITDA	SEK 438K	-48%
Net profit	SEK 261K	-48%
Total assets	SEK 1,9M	+8%
Equity	SEK 1,3M	+5%
Employees	—	—

Item	2021	2022	2023	2024	2025
Revenue	482	1 114	982	1 776	1 520
Staff expenses	—	−88	—	—	—
EBITDA	372	912	364	846	438
Depreciation & amort.	−0	—	−0	−0	−0
EBIT	372	912	364	846	438
Net financials	—	—	—	−3	1
Profit before tax	373	912	273	633	330
Tax	−80	—	−56	−131	−69
Net profit	293	912	217	502	261

Item	2021	2022	2023	2024	2025
Total assets	447	1 004	1 147	1 756	1 895
Equity	318	938	969	1 276	1 337
Long-term debt	0	—	0	0	0
Short-term debt	130	66	86	178	147
Total debt	130	66	86	178	147

Name	Role	Member since	Age	Other directorships
MS Mazen Saber	Deputy Board Member	2022	—	—
HH Hewre Hamad	Board of Directors	2024	—	—
AH Abbas Hamad	Deputy Board Member	2022	—	—
AI Awat Ismail Hamad	Board of Directors	2022	—	—

Person	Role here	Other companies
Mazen Saber	Deputy Board Member	0 companies
Hewre Hamad	Board of Directors	0 companies
Abbas Hamad	Deputy Board Member	0 companies
Awat Ismail Hamad	Board of Directors	0 companies

Noursken AB

ABActive

Org 5592648256Skvadronsbacken 64Business and other management consultancy activities · NACE 7020Est. 20205-9 employees

Full Risika report

Revenue 2025

SEK 1,5M

-14% vs 2024

EBITDA margin

28.8%

-48% vs 2024

Equity ratio

70.6%

Financial strength

Net profit 2025

SEK 261K

-48% vs 2024

EBITDA — year on yearSEK millions

Key figuresAnnual report 2025

Revenue	SEK 1,5M	-14%
EBITDA	SEK 438K	-48%
Net profit	SEK 261K	-48%
Total assets	SEK 1,9M	+8%
Equity	SEK 1,3M	+5%
Employees	—	—